Statins affect ocular microcirculation in patients with hypercholesterolaemia

Acta Ophthalmologica

Volumn 89, Issue 6, 2011, Pages

  Terai, Naim ^a   Spoerl, Eberhard ^a   Fischer, Sabine ^a   Hornykewycz, Karin ^a   Haustein, Michael ^a   Haentzschel, Janek ^a   Pillunat, Lutz E ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

hypercholesterolaemia; ocular microcirculation; statins

Indexed keywords

CHOLESTEROL; EZETIMIBE PLUS SIMVASTATIN; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; MICROCIRCULATION; MORNING DOSAGE; PLEIOTROPY; PRIORITY JOURNAL; RETINA ARTERY; RETINA BLOOD FLOW; RETINA BLOOD VESSEL; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION;

ADULT; AGED; ARTERIOLES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INTRAOCULAR PRESSURE; MALE; MICROCIRCULATION; MIDDLE AGED; PHOTIC STIMULATION; PHOTOGRAPHY; RETINAL VESSELS; TONOMETRY, OCULAR; TRIGLYCERIDES; VASODILATION; VENULES; YOUNG ADULT;

EID: 80052102930     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2011.02154.x     Document Type: Article

References (22)

1. Bayerle-Eder M, Fuchsjäger-Mayrl G, Sieder A, et al., (2002): Effect of pravastatin on responsiveness to N-monomethyl-L-arginine in patients with hypercholesterolaemia. Atherosclerosis 160: 177-184. (Pubitemid 34076653)
2. Delanty N, &, Vaughan CJ, (1997): Vascular effects of statins in stroke. Stroke 28: 2315-2320. (Pubitemid 27497940)
3. Elrod JW, &, Lefer DJ, (2005): The effects of statins on endothelium, inflammation and cardioprotection. Drug News Perspect 18: 229-236. (Pubitemid 41094925)
4. Garhofer G, Zawinka C, Resch H, et al., (2004): Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol 88: 887-891.
5. Haefliger IO, Flammer J, &, Luscher TF, (1993): Heterogeneity of endothelium-dependent regulation in ophthalmic and ciliary arteries. Invest Ophthalmol Vis Sci 34: 1722-1730. (Pubitemid 23120247)
6. Hein TW, &, Kuo L, (1999): cAMP-independent dilation of coronary arterioles to adenosine: role of nitric oxide, G proteins, and K(ATP) channels. Circ Res 85: 634-642. (Pubitemid 29467852)
7. Lakhan SE, Bagchi S, &, Hofer M, (2010): Statins and clinical outcome of acute ischemic stroke. Int Arch Med 3: 22.
8. Laufs U, La Fata V, Plutzky J, et al., (1998): Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97: 1129-1135. (Pubitemid 28152885)
9. Leung DY, Li FC, Kwong YY, et al., (2010): Simvastatin and disease stabilization in normal tension glaucoma: a cohort study. Ophthalmology 117: 471-476.
10. Lilja JJ, Kivisto KT, &, Neuvonen PJ, (1998): Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin Pharmacol Ther 64: 477-483. (Pubitemid 28531591)
11. Luksch A, Lasta M, Polak K, et al., (2009): Twelve-hour reproducibility of retinal and optic nerve blood flow parameters in healthy individuals. Acta Opthalmol 87: 875-880.
12. McGwin G Jr, McNeal S, Owsley C, et al., (2004): Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol 122: 822-826. (Pubitemid 38736240)
13. Nagaoka T, Takahashi A, Sato E, et al., (2006): Effect of systemic administration of simvastatin on retinal circulation. Arch Ophthalmol 124: 665-670.
14. Nagaoka T, Hein TW, Yoshida A, et al., (2007): Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways. Invest Ophthalmol Vis Sci 48: 825-832. (Pubitemid 351260719)
15. Owen CG, Carey IM, Shah S, et al., (2010): Hypotensive medication, statins, and the risk of glaucoma. Invest Ophthalmol Vis Sci 51: 3524-3530.
16. Polak K, Dorner G, Kiss B, et al., (2000): Evaluation of the Zeiss retinal vessel analyser. Br J Ophthalmol 84: 1285-1290.
17. Sacks FM, Pfeffer MA, Moye LA, et al., (1996): The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 335: 1001-1009. (Pubitemid 26338729)
18. Schmeer C, Kretz A, &, Isenmann S, (2007): Therapeutic potential of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors for the treatment of retinal and eye diseases. CNS Neurol Disord Drug Targets 6: 282-287. (Pubitemid 47232940)
19. Schmetterer L, &, Garhofer G, (2007): How can blood flow be measured? Surv Ophthalmol 52 (Suppl 2): S134-S138. (Pubitemid 350060964)
20. Senn B, Orgul S, Keller U, et al., (1999): Retrobulbar and peripheral capillary blood flow in hypercholesterolemic subjects. Am J Ophthalmol 128: 310-316. (Pubitemid 29413227)
21. Tang WH, &, Francis GS, (2010): Statin treatment for patients with heart failure. Nat Rev Cardiol 7: 249-255.
22. Terai N, Julius U, Haustein M,. et al. (2011): The effect of low-density lipoprotein apheresis on ocular microcirculation in patients with hypercholesterolemia: a pilot study. Br J Ophthalmol 95: 401-404.